Patients with heart failure with preserved ejection fraction (HFpEF) and evidence of pulmonary vascular disease (PVD) may benefit from targeted therapy with phosphodiesterase type 5 inhibitor (PDE5i), a recent study has found.
Bronchiolitis in infancy carries a three- to fivefold increased risk of developing respiratory illnesses, including asthma, wheeze, and lower and upper respiratory tract infections in the first 5 years of life, a study has found.
The tetracycline omadacycline is not inferior to moxifloxacin when used as empirical monotherapy for hospitalized adults with community-acquired bacterial pneumonia, according to the results of a phase III study.
Epicutaneous immunotherapy for peanut allergy delivered through a skin patch yields significantly greater response in terms of desensitization to peanut protein than placebo among children with peanut allergy, but misses a component of the primary endpoint to be considered “positive”, according to the PEPITES* study.
Patients with extensive stage small cell lung cancer (ES-SCLC) without brain metastasis who underwent prophylactic cranial irradiation (PCI) after achieving stable disease or better on first-line chemotherapy had improved overall survival (OS) compared with those who did not undergo PCI, according to a retrospective study from Singapore.
The use of magnesium supplements as an adjunct to standard asthma treatment in patients with mild-to-moderate disease confers no significant benefits apart from an improvement in forced expiratory volume in 1 second after 8 weeks of treatment, according to the results of a meta-analysis.
Getting vaccinated against influenza can improve survival of patients with heart failure (HF), with earlier and more frequent vaccination being associated with a greater protection against deaths from cardiovascular (CV) events or any cause, a large Danish nationwide cohort study shows.